Interestingly, the phosphorylation of p53 was increased in the liver tissues of AF-treated Akr1a1−/− mice compared to those in the AF-treated WT mice or PF-treated Akr1a1−/− mice (Fig. 5G). This evidence concerns the gene TP53 and atrial fibrillation.